Dr. Reddys Labs (RDY) Posts Improved Q2 EPS of 50c/Share

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.50, versus $0.30 reported last year. Revenue for the quarter came in at $544 million, versus $429 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Cooper Companies (COO) Reiterated at Buy by Stifel After Earnings Call